The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
Open accessAbstract
Considering the well established role of nonclassical HLA-G class I molecules in inhibiting natural killer (NK) cell function, the consequence of abnormal HLA-G expression in malignant cells should be the escape of tumors from immunosurveillance. To examine this hypothesis, we analyzed HLA-G expression and NK sensitivity in human malignant melanoma cells. Our analysis of three melanoma cell lines and ex vivo biopsy demonstrated that (i) IGR and M74 human melanoma cell lines exhibit a high level of HLA-G transcription with differential HLA-G isoform transcription and protein expression patterns, (ii) a higher level of HLA-G transcription ex vivo is detected in a skin melanoma metastasis biopsy compared with a healthy skin fragment from the same individual, and (iii) HLA-G protein isoforms other than membrane-bound HLA-G1 protect IGR from NK lysis. It thus appears of critical importance to consider the specific role of HLA-G expression in tumors in the design of future cancer immunotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J., & DeMars, R. (1990) · Science · doi:10.1126/science.2326636 · Cited by 1,407
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
Rouas-Freiss, N., Gonçalves, R. M.-B., Menier, C., Dausset, J., & Carosella, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11520 · Cited by 701
Self-citationThe activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., & Boon, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7149 · Cited by 542
Ishitani, A., & Geraghty, D. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3947 · Cited by 515
Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells
Pazmany, L., Mandelboim, O., Valés-Gómez, M., Davis, D. M., Reyburn, H. T., & Strominger, J. L. (1996) · Science · doi:10.1126/science.274.5288.792 · Cited by 497
Rouas-Freiss, N., Marchal, R. E., Kirszenbaum, M., Dausset, J., & Carosella, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5249 · Cited by 353
Self-citationMoretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., & Moretta, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00943.x · Cited by 350
Lee, N., Malacko, A. R., Ishitani, A., Chen, M.-C., Bajorath, J., Marquardt, H., & Geraghty, D. E. (1995) · Immunity · doi:10.1016/1074-7613(95)90130-2 · Cited by 312
Strickland, S., & Richards, W. G. (1992) · Cell · doi:10.1016/0092-8674(92)90503-5 · Cited by 301
Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast
King, A., Boocock, C., Sharkey, A. M., Gardner, L., Beretta, A., Siccardi, A. G., & Loke, Y. W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.6.2068 · Cited by 252
Stam, N. J., Vroom, T. M., Peters, P. J., Pastoors, E. B., & Ploegh, H. L. (1990) · International Immunology · doi:10.1093/intimm/2.2.113 · Cited by 250
Natural Killer Cells: From No Receptors to Too Many
Lanier, L. L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80280-0 · Cited by 222
Dependence of Peptide Binding by MHC Class I Molecules on Their Interaction with TAP
Grandea, A. G., Androlewicz, M. J., Athwal, R. S., Geraghty, D. E., & Spies, T. (1995) · Science · doi:10.1126/science.270.5233.105 · Cited by 184
Pérez‐Villar, J. J., Melero, I., Navarro, F., Carretero, M., Bellón, T., Llano, M., Colonna, M., Geraghty, D. E., & López‐Botet, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5736 · Cited by 169
Tefany, F. J., Barnetson, R. S., Halliday, G. M., McCarthy, S. W., & McCarthy, W. H. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12479662 · Cited by 159
King, A., Loke, Y. W., & Chaouat, G. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01001-3 · Cited by 118
Carosella, E. D., Dausset, J. B., & Kirszenbaum, M. (1996) · Immunology Today · doi:10.1016/0167-5699(96)30055-8 · Cited by 109
Self-citationPorgador, A., Mandelboim, O., Restifo, N. P., & Strominger, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13140 · Cited by 109
Tumor Escape from Immune Response by Variation in HLA Expression and Other Mechanisms
Bodmer, W. F., Browning, M. J., Krausa, P., Rowan, A., Bicknell, D. C., & Bodmer, J. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb43994.x · Cited by 107
Uterine NK Cells and Trophoblast HLA Class I Molecules
King, A., Hiby, S. E., Verma, S., Burrows, T. D., Gardner, L., & Loke, Y. W. (1997) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1997.tb00260.x · Cited by 102
Pende, D., Sivori, S., Accame, L., Pareti, L., Falco, M., Geraghty, D. E., Bouteiller, P. P. L., Moretta, L., & Moretta, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270809 · Cited by 91
Evidence for the expression of non-HLA-A,-B,-C class I genes in the human fetal liver
Houlihan, J. M., Biro, P. A., Fergar-Payne, A., Simpson, K. L., & Holmes, C. H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.668 · Cited by 76
Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells
Schust, D. J., Hill, A. B., & Ploegh, H. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3375 · Cited by 73
HLA-G gene polymorphism segregation within CEPH reference families
Kirszenbaum, M., Djoulah, S., HORS, J., Gall, I. L., de Oliveira, E. B., Prost, S., Dausset, J. B., & Carosella, E. D. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00038-4 · Cited by 49
Self-citationBull, M. J., van Hoef, A., & Gorski, J. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3792-3796.1990 · Cited by 24
Jones, J. A., Albright, K. D., Christen, R. D., Howell, S. B., & McClay, E. F. (1997) · PubMed · Cited by 17
Cited by
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. J., Makadzange, A., Rowland-Jones, S., Willcox, B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431057100 · Cited by 557
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Landen, C. N., Birrer, M. J., & Sood, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9970 · Cited by 462
Metadata
- Authors
- Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F. A., Avril, M. F., Dausset, J., Guillet, J. G., & Carosella, E. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-04-14
- Volume
- 95
- Issue
- 8
- Pages
- 4510-4515
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2160048269
- Cited by
- 432
- References
- 29
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.